Mathew Cherian Chief Operating Officer and Co-Founder Mathew Cherian is the Chief Operating Officer and Co-Founder of the company, bringing more than 34 years of international experience in the pharmaceutical industry across the United States and Europe. Before co-founding the organization, Mr. Cherian served as Director and Senior Fellow at a leading global pharmaceutical company. During his tenure, he played a key role in early stage product development and successfully coordinated research efforts across multiple global Pfizer sites. His extensive expertise in complex pharmaceutical products continues to support the development of innovative therapies across several therapeutic areas. Mr. Cherian is a recognized expert in drug device combination products and is a leader in advancing differentiated drug delivery systems, contributing to the development of high-value, advanced pharmaceutical solutions. He holds a Ph.D. in Chemical Engineering from the University of Rhode Island and is an inventor with multiple patents. Widely regarded as a thought leader in the industry, he regularly speaks at global pharmaceutical forums and serves on the Executive Committee of the International Pharmaceutical Society. enhance community well being.

Mohamed AlNadi Vice President, International Expansion and Partnerships (MENA and Africa) Dr. Mohamed Alnadi serves as the Vice President of International Expansion and Partnerships for the MENA and Africa regions. With over 25 years of experience in international trade, export operations, and strategic market growth, he has successfully expanded business footprints across more than 60 countries. Since 2002, Dr. Alnadi has led Alnadi Pharmacy Company, establishing it as a trusted name in the pharmaceutical and healthcare sectors. He previously held the position of Managing Director at EgyBelg for Industrial Investment, where he specialized in biotechnology and enzyme production. He also managed a leading food manufacturing company, driving its expansion across regional and global markets. Dr. Alnadi holds a Bachelor’s degree in Pharmacy from Cairo University and a Business Administration Diploma from the American University in Cairo.

Amany El Megharbel Vice President of Finance and Banking Strategy Amany El Megharbel brings more than 29 years of experience in banking and financial services, with deep expertise in private banking, asset management, and digital banking solutions. She previously served as Head of Branches, Financial Institutions, and Asset Management at Banque Misr UAE, where she played a key role in improving operational efficiency and profitability. Prior to that, she led the launch of BLOM Bank Egypt’s Private Banking division and drove innovative banking initiatives at Credit Agricole and Egyptian American Bank. Amany holds certifications in Wealth Management and Financial Planning and Asset Allocation, along with a Bachelor's degree in Commercial Sciences. Her extensive experience and financial leadership play a strategic role in supporting Dawah Pharma’s growth and long-term vision.

Contact Us for an EB5 or E2 Visa Investment Opportunity Submit

Dr. Hossam Abdel Maqsoud Hosts Diplomatic Dinner Celebrating the Appointment of Ambassador Mohamed El-Helwany as Egypt’s Ambassador to Guinea Dr. Hossam Abdel Maqsoud, Chairman of Dawah Pharma USA and Board Member of the Egyptian African Businessmen Association, hosted a dinner at the Diplomatic Club in honor of the appointment of Ambassador Mohamed El-Helwany as Egypt’s Ambassador to the Republic of Guinea The event was attended by distinguished figures from the diplomatic, economic, and media sectors, including: Dr. Abdelhakim El Waer, Assistant Director-General and Regional Representative for the Near East and North Africa – FAO H.E. Sim Monir Cisse, Ambassador of Guinea to Egypt Dr. Yousry El Sharkawy, President of the Egyptian African Businessmen Association Eng. Ahmed Al Assar, Chairman of Massar Mr. Magdy Mounir, Editor-in-Chief at Al-Ahram Dr. Wael Youssef, CEO of Al Nasr Export & Import Mr. Willy Dowlaty, Vice Chairman of Taamir Mr. Ahmed Yassin, Vice Chairman of Dawah Pharma Mr. Karim Ismail, Chairman of Scope Sports and Board Member of the Association Eng. Ahmed Samir, Board Member of the Association During the event, Dr. Abdel Maqsoud highlighted the company’s strong growth strategy across Africa, aiming to expand the presence of high-quality Egyptian pharmaceuticals into new markets—both across the African continent and from Egypt into the United States He also emphasized that Dawah Pharma is actively working towards securing U.S. FDA approval to reinforce global trust in Egyptian medical products and strengthen Egypt’s position as a key player in the international pharmaceutical industry

Strategic Partnerships Driving Global Pharmaceutical Impact At Dawah Pharmaceuticals, partnerships are more than just collaborations — they are long-term alliances built on shared values, innovation, and a deep commitment to advancing human health. JOIN US Dawah-Holdi International Dawah-Holdi International is a strategic joint venture between Dawah Pharmaceuticals and HoldiPharma, combining extensive pharmaceutical expertise and innovative manufacturing capabilities. This partnership leverages HoldiPharma's robust manufacturing infrastructure in Egypt with Dawah Pharmaceuticals' regulatory knowledge and market access to the United States, creating a synergistic approach to deliver high-quality, FDA-compliant generic medications. Dawah-Gypto International Dawah-Gypto International is a dedicated joint venture between Dawah Pharmaceuticals and Gypto Pharma, one of Egypt’s premier pharmaceutical manufacturing companies. The partnership focuses on modernizing production lines to meet stringent FDA standards, thereby facilitating the export of quality pharmaceutical products from Egypt to the U.S. This strategic collaboration uniquely positions Dawah-Gypto International to deliver cost-effective generic medications that adhere strictly to U.S. regulatory guidelines. QG International QG International is a strategic joint venture between Dawah Pharmaceuticals and QG Medical Devices, one of the Middle ,East's leading manufacturers of advanced medical devices .headquartered in Doha, Qatar This partnership aims to integrate Dawah's pharmaceutical expertise with QG's state-of-the-art production capabilities deliver high-quality, FDA-compliant medical devices and healthcare pipeline solutions. By combining Dawah's strong regulatory foundation and global network with QG's technological innovation and precision engineering, the collaboration paves the way for enhanced accessibility and affordability of world-class medical solutions across regiona .and international markets

Egypt Signs Strategic Tripartite Partnership to Build an Integrated Medical Manufacturing Ecosystem for Regional & Global Markets Read More Strategic Partnership Signed Between Dawah Pharma LLC (USA) and Bateel Group Holding Read More Dr. Hossam Abdel Maqsoud Hosts Diplomatic Dinner Celebrating the Appointment of Ambassador Mohamed El-Helwany as Egypt’s Ambassador to Guinea Read More GYPTO Pharma Signs Preliminary Agreement with Mozambique Government to Establish Regional Pharmaceutical Distribution Hub Read More Egypt’s Gypto Pharma (Medicine City) and US-based Dawa Pharmaceuticals signed a strategic alliance agreement aimed at strengthening Egypt’s pharmaceutical industry and achieving US Food and Drug Administration (FDA) qualification for Gypto Pharma’s facilities Read More

Dr. Hossam Abdel Maksoud Chief Executive Officer Nicholas Vartanian Chief Business Officer Mohamed AlNadi Vice President, International Expansion and Partnerships (MENA and Africa) Thomas Ingallinera Vice President of Operations Mathew Cherian Chief Operating Officer and Co-Founder Amany El Megharbel International Investment Advisor Dr. Helmy Nada Fund Manager, Dawah Holdings

We deliver care that connects communities to a healthier future. Dawah Pharmaceuticals is redefining access to essential medicine through a global platform built on science, trust, and collaboration. With a presence in the U.S., Egypt, and across the MENA region, our commitment goes beyond manufacturing "Filling the Gap" Dawah Pharmaceuticals is committed to addressing critical shortages in sterile injectable medications by bringing essential, FDA-compliant drugs to market. Through strategic partnerships with top-tier Contract Manufacturing Organizations (CMOs), we ensure a timely response to the healthcare industry's pressing needs. "Innovative Outsourcing Models" Leveraging our partnerships with global CMOs, Dawah Pharmaceuticals focuses on efficient, high-quality drug production without the constraints of traditional manufacturing. This approach allows us to accelerate timelines and maintain flexibility, ensuring that critical medications reach patients faster. "Strategic Growth and Market Entry" Our portfolio includes high-priority products produced exclusively through CMOs. By prioritizing collaboration and scalability, Dawah is building a sustainable framework to expand its market presence and deliver impactful solutions across multiple therapeutic areas. "Injectable and ophthalmic pharmaceutical company" We market and manufacture a growing portfolio of FDA-approved medicines, including several generic alternatives, in the United States. Our products include both injectable and ophthalmic prescription medicines. Explore Our Products Trusted pharmaceutical solutions designed with science View More ABOUT DAWAH Dawah Pharmaceuticals is a U.S.-based pharmaceutical company with a global vision and deep regional roots. Backed by over 30 years of leadership experience in healthcare, Dawah bridges U.S. regulatory expertise with Egyptian manufacturing excellence to deliver quality medicines worldwide. Through its strategic joint ventures Dawah-Gypto Pharma and Dawah-Holdi Pharma the company operates internationally accredited facilities producing over 200 million units annually. Dawah’s diverse portfolio spans sterile injectables, oral medications, and wellness products, all aligned with the highest global standards. Headquartered in the United States with an expanding footprint across Egypt and the MENA region, Dawah Pharma is committed to advancing quality, affordability, and access to care across continents. Our Team Contact Us Submit

GYPTO Pharma Signs Preliminary Agreement with Mozambique Government to Establish Regional Pharmaceutical Distribution Hub Dawah Gypto has signed a preliminary agreement with the Government of Mozambique to establish a regional pharmaceutical distribution hub and a packaging facility for liquid and semi-liquid medications This strategic step reinforces the company’s presence in the Southern African region, enhancing access to high-quality and affordable medicines within SADC countries. The collaboration reflects strong confidence in Dawah Gypto’s capabilities and its commitment to supporting sustainable healthcare development. The project will contribute to improving medicine availability, creating local job opportunities, and advancing technology transfer in the pharmaceutical sector. Dawah Gypto continues to expand its footprint across Africa with a clear vision to elevate healthcare standards and deliver life-saving treatments to communities across the continent.